Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SVRA compared with TRVI: revenue, margins and what each company keeps, and the suppliers and customers both name
SVRA
Savara Inc
Change
Mkt cap
Revenue
Revenue
TRVI
Trevi Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SVRA
Savara Inc
vs
TRVI
Trevi Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SVRA
7
—
FUJIFILM Diosynth Biotechnologies
unlisted
supplier
—
GEMA Biotech
unlisted
supplier
—
Parexel
unlisted
supplier
—
PARI Pharma GmbH
unlisted
supplier
3 more · SVRA chain
›
Shared
0
No shared counterparties.
Only TRVI
2
—
Keenova Therapeutics
unlisted
supplier
—
Par Health
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
SVRA
Savara Inc
Change
4.83
▲
+2.11%
Mkt cap
$990.3M
TRVI
Trevi Therapeutics, Inc.
Change
14.05
▲
+3.12%
Regular session
Nov 3 '26
Mkt cap
$1.9B
vs
Compare
Regular session
Nov 3 '26
SVRA
Savara Inc
vs
TRVI
Trevi Therapeutics, Inc.
4.83
▲
+2.11%
Price
14.05
▲
+3.12%
$990.3M
Mkt cap
$1.9B
Change
Change
SVRA
4.83
▲
+2.11%
vs
TRVI
14.05
▲
+3.12%
Regular session
Nov 3 '26